Deborah Ricci

Q: What is Deborah Ricci email address?

Email Deborah Ricci at dricci@its.jnj.com and dricci@prdus.jnj.com. This email is the most updated Deborah Ricci's email found in 2026.

Q: How to contact Deborah Ricci?

To contact Deborah Ricci send an email to dricci@its.jnj.com or dricci@prdus.jnj.com.

Sr. Director, Data Science Portfolio Management at The Janssen Pharmaceutical Companies of Johnson & Johnson | New York City Metropolitan Area

About Deborah Ricci

Deborah Ricci serves as the Senior Director of Oncology Translational Research at The Janssen Pharmaceutical Companies of Johnson & Johnson, where she leverages her extensive expertise in translational medicine to drive innovative solutions in drug development. With a keen focus on the intricacies of clinical trial processes, Deborah has established a robust framework for Hybrid Clinical Studies, which integrates traditional and decentralized methodologies to enhance patient engagement and data collection. Her pioneering work in developing a Protocol Optimization Design Suite utilizes real-world data (RWD) to refine inclusion and exclusion criteria, ensuring that clinical trials are not only scientifically rigorous but also more inclusive and representative of diverse patient populations.

In her role, Deborah has also spearheaded the creation of algorithms that streamline the schedule of activities, facilitating the consolidation and decentralization of visits in randomized controlled trials (RCTs). This initiative not only improves operational efficiency but also enhances the patient experience by reducing the burden of travel and increasing accessibility to cutting-edge therapies. Furthermore, her expansion of the tokenization global framework for RWD-RCT registries underscores her commitment to advancing data analytics in oncology research, allowing for more nuanced analyses that address critical questions in treatment efficacy and safety.

Deborah's leadership is characterized by a meticulous approach to risk assessment and mitigation, enabling her team to propose strategic solutions that align with key business goals and objectives. Her deep understanding of the pharmaceutical industry, combined with her passion for advancing oncology research, positions her as a pivotal figure in the quest to bring innovative therapies to patients in need. With a strong foundation in genomics, clinical development, and life sciences, Deborah Ricci continues to make significant contributions to the field, driving forward the future of oncology therapeutics.

Deborah Ricci Work